ArticleDrug design, development and therapy2024

CXCR2 Activated JAK3/STAT3 Signaling Pathway Exacerbating Hepatotoxicity Associated with Tacrolimus.

Xiao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.